Biofrontera BFRI
NASDAQ BFRI
$0.79 +0.01 (+0.77%)
As of: Oct 23, 2026 · 2:37 PM EDT

Biofrontera (BFRI) Net Debt Issuances and Repayments (2023 - 2024)

Updated

Analysis

Biofrontera (BFRI) Net Debt Issuances and Repayments (2023 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Debt Issuance (Qtr)
1 Eli Lilly 1,124.12 Bn 1,092.71 Bn 19.71 Bn 11.58 Bn
2 Johnson & Johnson 634.38 Bn 554.24 Bn 17.30 Bn -4.36 Bn
3 AbbVie 505.39 Bn 478.50 Bn 12.70 Bn -2.00 Bn
4 Merck 357.36 Bn 311.74 Bn 12.21 Bn -5.00 Mn
5 Novartis Ag 290.21 Bn 254.20 Bn 11.24 Bn 2.17 Bn
6 Astrazeneca 265.21 Bn 238.89 Bn 12.86 Bn -2.46 Bn
7 Amgen 237.81 Bn 193.21 Bn 7.24 Bn -
8 Gilead Sciences 194.79 Bn 168.99 Bn 6.22 Bn -17.00 Mn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 64.00 Mn
10 Biofrontera 10.17 Mn -11.62 Mn 9.59 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 -298,000.00
Jun 30, 2024 -2.15 Mn
Mar 31, 2024 -1.86 Mn
Dec 31, 2023 2.21 Mn
Sep 30, 2023 591,000.00
API Access

Biofrontera Net Debt Issuances and Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-debt-issuances-and-repayments&ticker=BFRI&period=max&api_key=YOUR_API_KEY